Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: Ropeginterferon Alfa-2b (P1101) Phase 3 Study in Interferon Treatment-Naive Subjects With HCV Genotype 2 Infection [Phase 3]
Phase 3 trial evaluating ropeginterferon alfa-2b (P1101) in interferon treatment-naive subjects with hepatitis C virus genotype 2; study com…
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C [Phase 4]
Phase 4 trial update on administering Zepatier (grazoprevir/elbasvir) in chronic hemodialysis patients with Hepatitis C; study completed wit…
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection. [Phase 3]
Phase 3 trial evaluating interferon-free treatment for recently acquired hepatitis C in people who inject drugs and those with HIV coinfecti…
-
CLINICAL_TRIALS trial_result · 2021-11-18Clinical Trial Update: A Direct obserVed therApy vs fortNightly CollEction Study for HCV Treatment - ADVANCE HCV Study [Phase 2]
A Phase 2 study investigating a direct-acting therapy for hepatitis C has completed enrollment with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-05Clinical Trial Update: Viekira Pak or Mavyret Treatment for Patient With Chronic Kidney Disease and Hepatitis C [Phase 4]
Phase 4 trial updating outcomes of Viekira Pak or Mavyret in patients with chronic kidney disease and chronic hepatitis C; completed with re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV) [Phase 2]
Phase 2 trial comparing two HIV/HCV treatments in patients co-infected with HIV and hepatitis C, evaluating effectiveness, safety, and toler…
-
CLINICAL_TRIALS trial_result · 2021-10-27Clinical Trial Update: Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection [Phase 3]
A Phase 3 trial investigated the efficacy and safety of sofusbuvir/velpatasvir (SOF/VEL) fixed-dose combination and SOF/VEL/voxilaprevir (SO…
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Treatment of Chronic Hepatitis C Infection by Ledipasvir/Sofosbuvir in Naïve Children [Phase 2]
Phase 2 trial evaluating ledipasvir/sofosbuvir in treatment-naïve children with chronic hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection [Phase 2]
Phase 2 dose-finding trial of Pegylated-P-Interferon-alpha-2b (P1101) in treatment-naive Hepatitis C genotype 1 patients completed.
-
CLINICAL_TRIALS trial_result · 2021-10-05Clinical Trial Update: A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects [Phase 2, Phase 3]
A completed pediatric trial program evaluated Hepatitis C treatment in children across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2021-09-21Clinical Trial Update: Simplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing World [Phase 4]
Phase 4 clinical trial update on simplifying hepatitis C antiviral therapy in Rwanda for broader use in the developing world.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Concentration-Controlled Ribavirin for the Treatment of Patients With Chronic Hepatitis C Virus Infection [Phase 4]
Phase 4 trial update on concentration-controlled ribavirin for chronic hepatitis C virus infection has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs [NA]
A completed clinical trial evaluating a smartphone-based aDOT treatment approach with fixed-dose elbasvir and grazoprevir in people who inje…
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis [Phase 3]
Phase 3 trial update on reversal of hepatic impairment in hepatitis C patients with early cirrhosis decompensation; study terminated with po…
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: A Study of the Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Post-transplant Treatment With Mavyret [Phase 2]
Phase 2 trial evaluating use of hepatitis C-positive donors for hepatitis C-negative lung transplant recipients with post-transplant treatme…
-
CLINICAL_TRIALS trial_result · 2021-09-01Clinical Trial Update: High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV [Phase 3]
Phase 3 trial update evaluating high-dose interferon and pegylated interferon as induction therapy in difficult-to-treat genotype 1 hepatiti…
-
CLINICAL_TRIALS trial_result · 2021-09-01Clinical Trial Update: DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO) [Phase 2, Phase 3]
A phase 2/3 clinical trial update on direct-acting antivirals (DAAs) for patients with chronic hepatitis C infection and HBV coinfection; st…
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection [Phase 4]
Phase 4 clinical trial comparing hepatic safety of raltegravir versus efavirenz in HIV patients coinfected with hepatitis C; results complet…
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China [Phase 4]
Phase 4 trial evaluating a 12-week SOF/VEL regimen with prophylactic TAF in treatment-naïve genotype 1-6 HCV/HBV coinfected adults, with or …
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV [NA]
Clinical trial update on interventions for heavy drinking among patients with HIV and HCV, with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection [Phase 4]
Phase 4 trial update monitoring Sofosbuvir/Velpatasvir (SOF/VEL) in treatment-naïve hepatitis C patients with active infection; results comp…
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal Circulation [NA]
Completed clinical trial assessing intra-individual reproducibility of non-invasive portal circulation assessment using HepQuant technology;…
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection [Phase 2, Phase 3]
Phase 2/3 pediatric trial evaluating pharmacokinetics, safety, and efficacy of Glecaprevir/Pibrentasvir in children with genotypes 1–6 chron…
-
CLINICAL_TRIALS trial_result · 2021-07-06Clinical Trial Update: Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir [Phase 2]
A Phase 2 trial evaluating an 8-week course of sofosbuvir/velpatasvir for acute hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Role of Pegylated Interferon in Combination With DAAs to Cure Hepatitis C As Soon As Possible - Hepatitis C [ASAP-C] [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial evaluated pegylated interferon in combination with direct-acting antivirals for hepatitis C, with results …